Blood pressure changes following extracorporeal shock wave lithotripsy in Kirkuk province

Kamaran Y. Muhammadamin; Muhammad A. Alshawni; Omeed O. Darweesh

doi:10.15218/zjms.2012.0043

Authors

Kamaran Y. Muhammadamin Department of Medical Biochemistry, College of Medicine, Hawler Medical University, Erbil, Iraq.
Muhammad A. Alshawni Department of Urology, College of Medicine, Kirkuk University, Kirkuk, Iraq.
Omeed O. Darweesh Kirkuk Health Directorate, Kirkuk, Iraq.

DOI:

https://doi.org/10.15218/zjms.2012.0043

Keywords:

ESWL, hypertension, clinical trial

Abstract

Background and Objectives: Hypertension has been reported as a possible sequela of extracorporeal shock wave lithotripsy, the aim to determine, in a clinical trial, the effect of extracorporeal shock wave lithotripsy (ESWL) on blood pressure. Methods: This study included 216 patients, aged (12-65) years, with asymptomatic renal stones that were undergo ESWL in lithotripter unit/ Azadi teaching hospital –Kirkuk Province. Blood pressure was recorded at randomly using a standardized protocol. Patients undergoing ESWL received a mean (±SD) of 3608.8 (±475.9) shocks over a mean (6.81) of sessions on one lithotripter. Patients were then followed-up assessing their blood pressure. Data were analyzed on an intention for the treatment basis. Results: At randomization (13.42) % of the study group was hypertensive. Of (320) patients referred to the study, (258) were recruited based on the inclusion and exclusion criteria. A total of (216) patients (83 % of patients included) completed follow up, (137) (63.42%) were male and (79) (36.57%) were female. The mean follow-up peiod was (15.03) months. In the present study there was no association between mean diastolic and systolic blood pressure before and after ESWL. Conclusions: In the present study which included a randomized controlled clinical trial there was no evidence that ESWL causes changes in BP. More randomized control trials are needed to demonstrate the relationship between ESWL and hypertension.

Metrics

Metrics Loading ...

References

Chaussy C, Schuller J, Schmiedt E, Brandl H, Jocham D, Liedl B. Extracorporeal shock-wave lithotripsy (ESWL) for treatment of urolithiasis. Urology, 1984; 23:59–66.

Moody JA, Evans AP, Lingeman JE. Extracorporeal shockwave lithotripsy. In: Weiss RM, George NJR, O’Reilly PH, editors. Comprehensive Urology. Mosby International Limited, 2001. p. 623–36.

Chaussy C, Schmiedt E, Jocham D, et al. Extracorporeal shock wave lithotripsy: new aspects in the treatment of kidney stone disease. New York: S. Karger, 1982.

Evan AP, Willis LR, Connors B, Reed G, McAteer JA, Lingeman JE. Shock wave lithotripsy-induced renal injury. Am J Kid Dis, 1991; 17: 445±50.

Koga H, Matsuoka K, Noda S, Yamashita T. Cumulative renal damage in dogs by repeated treatment with ESWL. Int J Urol, 1996; 3: 134±40.

Peterson JC, Finlayson B. Effects of ESWL on blood pressure. In: Gravenstein J, Peter K, eds. Extracorporeal shock wave lithotripsy for renal stones disease. Boston, MA: Butterworths, 1986, p 145-6.

Watts RA, Hoffbrand BI. Hypertension following renal trauma (review). J Hum Hypertens, 1987; 1:65.

Lingeman JE, Kulb TB. Hypertension following extracorporeal shock wave lithotripsy. J Urol, 1987; 137:142A.

Williams C. M., Kaude J. V., Newman R. C. et al. Extracorporeal shock-wave lithotripsy: long-term complications. A.J.R.1988, 311-315.

Montgomery BS, Cole RS, Palfrey EL, Shuttleworth KE. Does ESWL cause hypertension? Br J Urol, 1989; 64: 567±71.

Liedl B, Jocham D, Lunz C, Schuster C, Schmiedt E. Five-year follow-up of urinary stone patients treated with extracorporeal shock wave lithotripsy. J Endourol, 1988; 2:157-62.

Claro Jde A, Lima ML, Ferreira U, Rodrigues Netto N Jr. Blood pressure changes after extracorporeal shock wave lithotripsy in normotensive patients. J Urol, 1993; 150(6):1765-7.

Zanetti GR, Montanari E, Guarneri A, Trinchieri A, Mandressi A, Ceresoli A. Long-term followup after extracorporeal shock wave lithotripsy treatment of kidney stones in solitary kidneys. J Urol, 1992; 148(3 Pt 2):1011- 4.

Chobanian AV, Bakris GL, Black HR et al "Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure", 2003: 1206–52.

Newman RC, Williams CM, Kaude J, Peterson J, Thomas WC. Hypertension following ESWL. In Proceedings of the Fifth World Congress on Endourology and ESWL, 1987: Abs0/230.

Germinale F, Puppo P, Bottino P, Caviglia C, Ricciotti G. ESWL and hypertension: No evidence for causal relationship. J Urol, 1989; 141: 288A.

Sandlow JI, Win®eld HN, Loening SA. Blood pressure changes related to ESWL. J Urol, 1989; 141: 290A.

Jewett MAS, Bombardier C, Logan AG et al. A randomized controlled trial to assess the incidence of new onset hypertension in patients after shockwave lithotripsy for asymptomatic renal calculi. J Urol, 1998; 160: 1241±3.

Yokoyama M, Shoji F, Yanagizawa R et al. Blood pressure changes following ESWL for urolithiasis. J Urol, 1992; 147: 553±8.

Vaughan ED, Tobin JN, Alderman R et al. Extracorporeal shock wave monotherapy does not cause renal dysfunction elevated blood pressure. J Urol, 1996; 155: 539A.

Lingeman. Commentary on ESWL and blood pressure. J Urol, 1995; 154: 2±4.

Zwergel TBH, Neissius D, Zergel UE, et al. Hypertension after extracorporeal shock wave lithotripsy: incidence following treatment with HM-3 lithotripter or Wolf Piezolith 2300 lithotripter. In: Lingeman JE, Newman DM, eds. Shock wave lithotripsy: Urinary and biliary. New York: Plenum Press, 1989, p 210-3.